Search results
Results from the WOW.Com Content Network
[9] [10] If rifamycin binds the polymerase after the chain extension process has started, no inhibition is observed on the biosynthesis, consistent with a steric-occlusion mechanism. Single step high level resistance to the rifamycins occurs as the result of a single amino acid change in the bacterial DNA dependent RNA polymerase.
Rifampicin is of the rifamycin group of antibiotics. [3] It works by decreasing the production of RNA by bacteria. [3] Rifampicin was discovered in 1965, marketed in Italy in 1968, and approved in the United States in 1971. [5] [6] [7] It is on the World Health Organization's List of Essential Medicines. [8]
It produces the rifamycin antibiotics (e.g., rifamycin SV), which are used to treat mycobacterial diseases such as tuberculosis and leprosy. [2] The type strain of Amycolatopsis rifamycinica (DSM 46095) has been reclassified several times. When it was first isolated from a French soil sample in 1957, it was identified as Streptomyces ...
Pages in category "Rifamycin antibiotics" The following 7 pages are in this category, out of 7 total. This list may not reflect recent changes. R. Rifabutin;
Rifaximin, is a non-absorbable, broad spectrum antibiotic mainly used to treat travelers' diarrhea.It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in over more than 30 countries for the treatment of a variety of gastrointestinal diseases like irritable bowel syndrome, and hepatic encephalopathy.
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
This page was last edited on 5 November 2023, at 03:47 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Scientists at the Italian drug company Achifar discovered rifabutin in 1975. (Eventually Archifar became part of Farmitalia Carlo Erba, a unit of the conglomerate Montedison which was subsequently bought by Pharmacia) This company's Adria Laboratories subsidiary filed for Food and Drug Administration (FDA) approval of rifabutin under the brand name Mycobutin in the early 1990s and the drug ...